Involvement of p38 mitogen-activated protein kinase in different stages of thymocyte development

Blood

Volumn 101, Issue 3, 2003, Pages 970-976

  Hsu, Shu Ching ^a,b,c,d   Wu, Chia Cheng ^a,b,c,d   Han, Jiahuai ^a,b,c,d   Lai, Ming Zong ^a,b,c,d  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SELECTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; GENE MUTATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE;

EID: 0037307045     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0744     Document Type: Article

References (45)

1. Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BM. T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J Biol Chem. 1997;272:15023-15027.
2. Salmon RA, Foltz IN, Young PR, Schrader JW. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptor, Fas, or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptor. J Immunol. 1997;159:5309-5317.
3. Matsuda S, Moriguchi T, Koyasu S, Nishida E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J Biol Chem. 1998;273:12378-12382.
4. Schafer PH, Wang L, Wadsworth SA, Davis JE, Siekierka JJ. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-α production in a manner distinct from LPS activation of monocytes. J Immunol. 1999;162:659-668.
5. Zhang J, Salojin KV, Gao JX, Cameron MJ, Bergerot I, Delovitch T. p38 Mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J Immunol. 1999;162:3819-3829.
6. Hsu SC, Gavrilin M, Tsai MH, Han J, Lai MZ, p38 mitogen activated protein kinase is involved in Fas ligand expression. J Biol Chem. 1999;274:25769-25776.
7. Yu CT, Shih HM, Lai MZ. Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation. J Immunol. 2001;166:284-292.
8. Dérijard B, Raingeaud J, Barret T, et al. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 1995;267:683-685.
9. Han J, Lee JD, Jiang Y, Li Z, Feng L, Ulevitch RJ. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem. 1996;271:2886-2891.
10. Moriguchi T, Kuroyanagi N, Yamaguchi K, et al. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem. 1996;271:13675-13679.
11. Raingeaud J, Whitmarsh AJ, Barret T, Dérijard B, Davis RJ. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol. 1996;16:1247-1255.
12. Cuenda A, Cohen P, Buee-Scherrer V, Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 1997;16:295-305.
13. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 1997;16:3563-3571.
14. Wang XS, Diener K, Manthey CL, et al. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem. 1997;272:23668-23674.
15. Hale KK, Trollinger D, Rihanek M, Manthey CL. Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J Immunol. 1999;162:4246-4252.
16. Jameson SC, Hogquist KA, Bevan M. Positive selection of thymocytes. Annu Rev Immunol. 1995;13:93-126.
17. Fisher A, Malissen B. Natural and engineered disorders of lymphocyte development. Science. 1998;280:237-243.
18. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi P. Selection of the T cell repertoire. Annu Rev Immunol. 1999;17:829-874.
19. Swan KA, Alberola-Ila J, Gross JA, et al. Involvement of p21 ras distinguishes positive and negative selection in thymocytes. EMBO J. 1995;14:276-285.
20. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Permutter RM. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature. 1995;373:620-623.
21. Pagès G, Guérin S, Grall D, et al. Defective thymocyte maturation in p44 MAP kinase (Erk1) knockout mice. Science. 1999;286:1374-1377.
22. Werlen G, Hausmann B, Palmer E. A motif in the αβ T-cell receptor controls positive selection by modulating ERK activity. Nature. 2000;406:422-426.
23. Delgado P, Fernandez E, Dave V, Kappes D, Alarcon B. CD3δ couples T-cell receptor signalling to ERK activation and thymocyte positive selection. Nature. 2000;406:426-430.
24. Dong C, Yang DD, Tourier C, et al. JNK is required for effector T-cell function but not for T-cell activation. Nature. 2000;405:91-94.
25. Diehl NL, Enslen H, Fortner KA, et al. Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo. J Exp Med. 2000;191:321-334.
26. Mulroy T, Sen J. p38 MAP kinase activity modulates alpha beta T cell development. Eur J Immunol. 2001;31:3056-3063.
27. Sugawara T, Moriguchi T, Nishida E, Takahama Y. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity. 1998;9:565-574.
28. + stage requires an active p38 mitogen-activated protein kinase. Blood. 2000;95:1356-1361.
29. Rincón M, Ensen H, Raingeaud J, et al. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 1998;17:2817-2829.
30. Lu HT, Yang DD, Wysk M, et al. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 1999;18:1845-1857.
31. Adams RH, Porras A, Alonso G, et al. Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol Cell. 2000;6:109-116.
32. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med. 2000;191:859-870.
33. Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M. Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell. 2000;102:221-231.
34. Jiang Y, Chen C, Li Z, et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem. 1996;271:17920-17926.
35. Huang S, Jiang Y, Li Z, et al. Apoptosis signaling pathway in T cells is composed of ICE/CED-3 family proteases and MAP kinase kinase 6b. Immunity. 1997;6:739-749.
36. Greaves DR, Wilson FD, Lang G, Kioussis D. Human CD2 3′-flanking sequences confer highlevel, T cell-specific, position-independent gene expression in transgenic mice. Cell. 1989;56:979-986.
37. Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB. J Exp Med. 1997;185:1897-1907.
38. Jiang Y, Gram H, Zhao M, et al. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ. J Biol Chem. 1997;272:30122-30128.
39. Sen J, Kapeller R, Fragoso R, Sen R, Zon LI, Burakoff SJ. Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. J Immunol. 1996;156:4535-4538.
40. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr Opin Immunol. 2000;12:186-192.
41. Bendelac A, Matzinger P, Seder RA, Paul WE, Schwartz RH. Activation events during thymic selection. J Exp Med. 1992;175:731-742.
42. Brandle D, Muller S, Muller C, Hengartner H, Pircher H. Regulation of Rag-1 and CD69 expression in the thymus during positive and negative selection. Eur J Immunol. 1994;24:145-151.
43. + thymocytes: increased synthesis of TCR-α protein is an early response to TCR signaling that compensates for TCR-α instability, improves TCR assembly, and parallels other indicators of positive selection. J Exp Med. 1995;181:193-202.
44. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature. 1989;341:746-749.
45. Teh HS, Kisielow P, Scott B, et al. Thymic major histocompatibility complex antigens and the αβ T cell receptor determine the CD4/CD8 phenotype of T cells. Nature. 1988;335:229-233.